Cargando…
The effect of disease modifying therapies on CD62L expression in multiple sclerosis
BACKGROUND: The increasing armamentarium of disease-modifying therapies in multiple sclerosis is accompanied by potentially severe adverse effects. The cell-adhesion molecule CD62L, which facilitates leukocyte extravasation, has been proposed as a predictive marker for treatment tolerability. Howeve...
Autores principales: | Voortman, Margarete Maria, Greiner, Paul, Moser, Daniel, Stradner, Martin Helmut, Graninger, Winfried, Moser, Adrian, Haditsch, Bernd, Enzinger, Christian, Fuchs, Siegrid, Fazekas, Franz, Fessler, Johannes, Khalil, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149021/ https://www.ncbi.nlm.nih.gov/pubmed/30263146 http://dx.doi.org/10.1177/2055217318800810 |
Ejemplares similares
-
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy
por: Gattringer, Thomas, et al.
Publicado: (2014) -
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
por: Fasching, Patrizia, et al.
Publicado: (2017) -
Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function
por: Pinter, Daniela, et al.
Publicado: (2019) -
Mucosal biopsy shows immunologic changes of the colon in patients with early MS
por: Moser, Adrian Mathias, et al.
Publicado: (2017) -
Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis
por: Pinter, Daniela, et al.
Publicado: (2014)